KATHY ROBERTS: Open Payments
NPI 1083349658 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 12 payments from 7 companies in 2025. Trend: 2023 $129 · 2024 $546 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| Vanda Pharmaceuticals Inc. | 2 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Lundbeck LLC | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 1 | $47 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
Products named: REXULTI, CAPLYTA, HETLIOZ, INVEGA SUSTENNA, COBENFY, ZENPEP.
Industry payments across NY — which companies pay providers there.
